How Teyro Works: End-to-End CDMO Solutions



Teyro simplifies pharmaceutical development with a structured CDMO (Contract Development & Manufacturing Organization) model, ensuring efficiency, compliance, and scalability from concept to commercialization.

How Teyro Works: End-to-End CDMO Solutions



Teyro simplifies pharmaceutical development with a structured CDMO (Contract Development & Manufacturing Organization) model, ensuring efficiency, compliance, and scalability from concept to commercialization.

World-Class USFDA & EU GMP Complaints Sterile & Non-Sterile Oncology Product Manufacturing

20+ Years

of CDMO Expertise

100+

Formulations Developed

cGMP& Global Regulatory

Approvals like USFDA, EMA (Germany), WHO and more.

Seamless
Scale-Up

Precision Manufacturing
& Testing

Our Process: From Development to Delivery

1. Research & Formulation

  • Custom drug formulation for oral solids, injectables, suspensions, and complex generics.
  • Process optimization for bioavailability, stability, and scalability.
  • Pre-formulation studies, excipient compatibility, and prototype development.

2. Analytical & Stability Testing

  • In-house laboratories for method development, validation, and ICH-compliant stability studies.
  • Quality control at every stage, ensuring regulatory compliance.
  • Accelerated and real-time stability testing for predictable shelf-life. 

3. Scale-Up, Technology Transfer & Commercial Manufacturing

  • Sterile & Non-Sterile Manufacturing for Oncology, High-potent and Specialty Formulations with multiple dosage forms like Injectable-Liquid & Lyophilized Vials, Tablets, Hard /soft Capsules, Powder.
  • Scalable Production – Pilot batches to full commercial manufacturing with stringent quality assurance.
  • Advanced Aseptic Production Facilities – Equipped with fully automated BOSCH Filling lines, MARTIN CHRIST Lyophilizers with Auto-Loading & Un-loading system, FEDEGARI Autoclaves,
  • Compounding & Aseptic Filtration capacity for 25 Litres to 1000 Litres under Closed contained system with programmed CIP and SIP systems and facilities.
  • Aseptic processing under Isolator and RABS technology integrated with BOSCH Integrated Filling line with an operating capacity of 15 million Vials per annum with a aseptic filling range from 1 mL to 100 mL vial sizes.
  • Oral Solids processing under isolator containment equipped with GEA granulation line & Compression machine, LB Bohle Coating machine, MG2 Capsule filling machine and CVC Bottle Packing line with an annual operating capacity of 150 million each tablet and capsules.

4. Regulatory & Market Readiness

  • Full regulatory support, dossier preparation, and global compliance.
  • End-to-end tech transfer for seamless scale-up and commercialization.
  • Post-approval support, documentation, and continuous monitoring.

Beyond Manufacturing

At Teyro, CDMO is more than just manufacturing—it’s a strategic partnership. Our integrated approach ensures efficiency, cost-effectiveness, and speed without compromising quality.

Oncology Expertise.
CDMO Excellence.

Teyro Labs works as an extension of your team to deliver results that matter.
Let’s make it happen.